A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers (Q36601503)
Jump to navigation
Jump to search
scientific article published on September 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers |
scientific article published on September 1997 |
Statements
1 reference
A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers (English)
1 reference
A V Schally
1 reference
N Lamharzi
1 reference
K Szepeshazi
1 reference
G Halmos
1 reference
K Groot
1 reference
J E Horvath
1 reference
1 September 1997
1 reference
10913-10918
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference